Efficacy of thalidomide in management of bleeding from gastrointestinal angiodysplasia

No abstract is available for this paper.

• Publication year

  2016

• Venue

  Cochrane Database of Systematic Reviews

• Publication date

  2016-12-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/14651858.CD012461PMCID PMC6463944
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Indicaciones terapéuticas actuales de la talidomida y la lenalidomida

  2014cited by this paper
• What's Hot in the Red Journal This Month

  2014cited by this paper
• Distribution of bleeding gastrointestinal angioectasias in a Western population.

  2012cited by this paper
• Role of vascular endothelial growth factor in angiodysplasia: An interventional study with thalidomide

  2012cited by this paper
• From clinical observation to mechanism--Heyde's syndrome.

  2012cited by this paper
• Thalidomide: An Old Drug with New Action

  2011cited by this paper
• Efficacy of thalidomide for refractory gastrointestinal bleeding from vascular malformation.

  2011cited by this paper
• Somatostatin Analogues in the Treatment of Recurrent Bleeding from Gastrointestinal Vascular Malformations: An Overview and Systematic Review of Prospective Observational Studies

  2010cited by this paper
• Vascular lesions of the gastrointestinal tract.

  2008cited by this paper
• A Pilot Study of Thalidomide in Recurrent GI Bleeding Due to Angiodysplasias

  2008cited by this paper
• Gastrointestinal angiodysplasia in chronic renal failure.

  2008cited by this paper
• Gastrointestinal bleeding in von Willebrand disease.

  2006cited by this paper
• Endoscopic therapy for upper-GI vascular ectasias.

  2004cited by this paper
• Hormonal therapy for gastrointestinal angiodysplasia.

  2002cited by this paper
• A multicenter, randomized, clinical trial of hormonal therapy in the prevention of rebleeding from gastrointestinal angiodysplasia.

  2001cited by this paper
• Increased expression of angiogenic factors in human colonic angiodysplasia.

  1999cited by this paper
• Proposal for an endoscopic classification of digestive angiodysplasias for therapeutic trials. The European Club of Enteroscopy.

  1998cited by this paper
• Prevalence and natural history of colonic angiodysplasia among healthy asymptomatic people.

  1995cited by this paper
• Thalidomide is an inhibitor of angiogenesis.

  1994cited by this paper
• Angiodysplasia of the gastrointestinal tract.

  1993cited by this paper
• Angiodysplasia: current concepts.

  1988cited by this paper
• Angiodysplasia — an uncommon cause of colonic bleeding: Colonoscopic evaluation of 1,050 patients with rectal bleeding and anaemia

  1987cited by this paper
• The pattern of angiodysplasia of the gastrointestinal tract in a tropical country.

  1985cited by this paper
• Angiodysplasia as a cause of upper gastrointestinal bleeding.

  1985cited by this paper
• Angiodysplasia

  1984cited by this paper

• No citing papers are available for this paper.